Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 160.00
+10.50 (7.02%)
At close: Feb 11, 2026
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 248 billion as of February 11, 2026. Its market cap has increased by 161.53% in one year.
Market Cap
248.00B
Enterprise Value
241.49B
Revenue
34.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
160.00
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 248.00B, an increase of 3,016.19%. That is a compound annual growth rate of 199.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 248.00B | 3.23% |
| Dec 31, 2025 | 240.25B | 154.60% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pell Bio-Med Technology | 43.85B |
| Lin BioScience | 33.05B |
| Lumosa Therapeutics | 32.60B |
| Oneness Biotech | 28.08B |
| Polaris Group | 23.11B |
| Sunmax Biotechnology | 21.35B |
| EirGenix | 18.28B |
| TaiMed Biologics | 14.89B |